Gene expression variation to predict 10-year survival in lymph-node-negative breast cancer.
Journal article, 2008

It is of great significance to find better markers to correctly distinguish between high-risk and low-risk breast cancer patients since the majority of breast cancer cases are at present being overtreated.

Follow-Up Studies

Kaplan-Meier Estimate

genetics

mortality

Biological

Female

Tumor Markers

genetics

Ductal

pathology

Humans

diagnosis

Breast

Gene Expression Profiling

Cluster Analysis

genetics

Predictive Value of Tests

Breast Neoplasms

Oligonucleotide Array Sequence Analysis

pathology

mortality

Lymphatic Metastasis

Carcinoma

diagnosis

Prognosis

Middle Aged

Author

Elin Karlsson

University of Gothenburg

Ulla Delle

University of Gothenburg

Anna Danielsson

University of Gothenburg

Björn Olsson

Frida Abel

University of Gothenburg

Per Karlsson

University of Gothenburg

Khalil Helou

University of Gothenburg

BMC Cancer

1471-2407 (ISSN)

Vol. 8 254-

Subject Categories

Basic Medicine

Clinical Medicine

DOI

10.1186/1471-2407-8-254

PubMed

18778486

More information

Created

10/10/2017